https://www.managedhealthcareexecutive.com/view/analyzing-the-cost-effectiveness-of-entresto-in-heart-failure
0
0
34 words
0
Comments
The findings reported in JAMA Cardiology suggest that Entresto is more cost effective in patients with heart failure with lower ejection fractions.
You are the first to view
Create an account or login to join the discussion